Cargando…

Factors Associated with Human Papillomavirus Vaccination among Women in the United States

BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Alexis, Archie-Booker, Elaine, Waldrop, Reinetta T., Claridy, Mechelle, Gerbi, Gemechu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258057/
https://www.ncbi.nlm.nih.gov/pubmed/30498798
http://dx.doi.org/10.20431/2456-0596.0301002
_version_ 1783374436567613440
author Sims, Alexis
Archie-Booker, Elaine
Waldrop, Reinetta T.
Claridy, Mechelle
Gerbi, Gemechu
author_facet Sims, Alexis
Archie-Booker, Elaine
Waldrop, Reinetta T.
Claridy, Mechelle
Gerbi, Gemechu
author_sort Sims, Alexis
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US. METHODS: Data from the 2014 Behavioral Risk Factor Surveillance System were used to assess predictors of HPV vaccination. A multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). Analyses were conducted using SAS Version 9.4. RESULTS: Factors that decreased the likelihood of receiving HPV vaccination included: being between the ages of 27–50 (AOR: 0.08; 95% CI: 0.06–0.11), having some college education, and residing in the South Black Belt States (AOR: 0.49; 95% CI: 0.31–0.78), Midwest (AOR: 0.63; 95% CI: 0.44–0.90), and the West (AOR: 0.37; 95% CI: 0.15–0.95). Factors that decreased the likelihood of receiving HPV vaccination to completion included: being Non-Hispanic Black (AOR: 0.26; 95% CI: 0.11–0.64), Hispanic (AOR: 0.26; 95% CI: 0.10–0.68), between the ages of 27–50 years (AOR: 0.46; 95% CI: 0.26–0.84), and residing in the Midwest (AOR: 0.36; 95% CI: 0.18–0.73) and South Remainder (non- Black Belt) states (AOR: 0.30; 95% CI: 0.09–0.93). CONCLUSION: Our results suggest that sociodemographic disparities still exist in more recent data underscoring the urgent need for additional efforts to increase HPV vaccination in populations that are least likely to receive the vaccination.
format Online
Article
Text
id pubmed-6258057
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62580572018-11-27 Factors Associated with Human Papillomavirus Vaccination among Women in the United States Sims, Alexis Archie-Booker, Elaine Waldrop, Reinetta T. Claridy, Mechelle Gerbi, Gemechu ARC J Public Health Community Med Article BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US. METHODS: Data from the 2014 Behavioral Risk Factor Surveillance System were used to assess predictors of HPV vaccination. A multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). Analyses were conducted using SAS Version 9.4. RESULTS: Factors that decreased the likelihood of receiving HPV vaccination included: being between the ages of 27–50 (AOR: 0.08; 95% CI: 0.06–0.11), having some college education, and residing in the South Black Belt States (AOR: 0.49; 95% CI: 0.31–0.78), Midwest (AOR: 0.63; 95% CI: 0.44–0.90), and the West (AOR: 0.37; 95% CI: 0.15–0.95). Factors that decreased the likelihood of receiving HPV vaccination to completion included: being Non-Hispanic Black (AOR: 0.26; 95% CI: 0.11–0.64), Hispanic (AOR: 0.26; 95% CI: 0.10–0.68), between the ages of 27–50 years (AOR: 0.46; 95% CI: 0.26–0.84), and residing in the Midwest (AOR: 0.36; 95% CI: 0.18–0.73) and South Remainder (non- Black Belt) states (AOR: 0.30; 95% CI: 0.09–0.93). CONCLUSION: Our results suggest that sociodemographic disparities still exist in more recent data underscoring the urgent need for additional efforts to increase HPV vaccination in populations that are least likely to receive the vaccination. 2018 /pmc/articles/PMC6258057/ /pubmed/30498798 http://dx.doi.org/10.20431/2456-0596.0301002 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Sims, Alexis
Archie-Booker, Elaine
Waldrop, Reinetta T.
Claridy, Mechelle
Gerbi, Gemechu
Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title_full Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title_fullStr Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title_full_unstemmed Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title_short Factors Associated with Human Papillomavirus Vaccination among Women in the United States
title_sort factors associated with human papillomavirus vaccination among women in the united states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258057/
https://www.ncbi.nlm.nih.gov/pubmed/30498798
http://dx.doi.org/10.20431/2456-0596.0301002
work_keys_str_mv AT simsalexis factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates
AT archiebookerelaine factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates
AT waldropreinettat factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates
AT claridymechelle factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates
AT gerbigemechu factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates